Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-04-26

Clinical Trial Update: Testing the Accuracy of a Personal Heart Rhythm Monitor to Detect Prolonged Paroxysmal Atrial Fibrillation [Phase 3]

View source ↗

Summary

This document notes the withdrawal of a Phase 3 clinical trial evaluating a personal heart rhythm monitor for detecting prolonged paroxysmal atrial fibrillation…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Surrey | Conditions: Paroxysmal Atrial Fibrillation, Stroke | Phase 3 | Status: WITHDRAWN